Blog Posts

Katy Rezvani Gave One of the 2025 Susan Swerling Lecture on NK Cell Therapy at Dana-Farber Cancer Institute

Katy Rezvani/LinkedIn

Jun 27, 2025, 06:40

Katy Rezvani Gave One of the 2025 Susan Swerling Lecture on NK Cell Therapy at Dana-Farber Cancer Institute

Katy Rezvani, Vice President and Head of Institute for Cell Therapy Discovery and Innovation at MD Anderson Cancer Center, shared a post on LinkedIn:

“On Tuesday, I had the privilege of giving one of the 2025 Susan Swerling Lectures at The Dana-Farber Cancer Institute, Harvard Medical School, as part of this year’s series on Engineering of Therapeutic Immune Cells.

It was a pleasure to share our work on NK cell therapy from MD Anderson, and to reflect on the clinical and scientific progress made possible through the efforts of so many exceptional colleagues, collaborators, and patients.

I’m especially grateful to the organizers for the kind invitation, and to the Dana-Farber community for such a warm and thoughtful welcome.”

More posts featuring Katy Rezvani on OncoDaily.

2025 Susan Swerling Lectures cancer Dana-Farber Cancer Institute Engineering of Therapeutic Immune Cells Harvard Medical School Katy Rezvani MD Anderson Cancer Center NK cell therapy OncoDaily Oncology

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Writer?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...